|
|
Volumn 29, Issue SUPPL. 2, 1996, Pages 34-36
|
|
Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: The argument for
|
|
Author keywords
Anandron ; Antiandrogens; Bicalutamide; Casodex ; Combined androgen blockade; Eulexin ; Flutamide; Hormonal therapy; Nilutamide; Patient subgroups; Prostate cancer, advanced
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
ANTIANDROGEN;
BICALUTAMIDE;
FLUTAMIDE;
NILUTAMIDE;
PROSTATE SPECIFIC ANTIGEN;
ADVANCED CANCER;
ALKALINE PHOSPHATASE BLOOD LEVEL;
CANCER PALLIATIVE THERAPY;
CASTRATION;
CONFERENCE PAPER;
HORMONAL THERAPY;
HUMAN;
MALE;
METASTASIS;
PAIN;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
|
|
EID: 0029929706
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000473836 Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
